Document is current

Any future updates will be listed below

Retrospective analysis of second-line chemotherapy outcomes with paclitaxel or docetaxel in correlation with STMN1 polymorphism in advanced non-small cell lung cancer patients

Crossref DOI link: https://doi.org/10.1007/s12094-015-1333-8

Published Online: 2015-07-07

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark